Enliven Therapeutics moves HQ from Boulder to California

▤ Summary

Enliven Therapeutics moved its headquarters from Boulder to Burlingame, California, while keeping some operations and early-stage research work in Boulder. The company says its principal executive offices are now in California and it has already leased office space in Burlingame. Enliven continues to advance its precision oncology pipeline, including ELVN-001, which is expected to enter a new trial phase in late 2026. The company also reported a strong cash position and runway into the first half of 2029. The move aligns leadership and operations closer to the Bay Area life sciences ecosystem.

▦ Linked Companies